Menu

Price Performance Heatmap

5Y Price (Market Cap Weighted)

All Stocks (1108)

Company Market Cap Price
BLGO BioLargo, Inc.
Clyra Medical infection control products classify BioLargo under Medical Devices & Biometrics.
$49.44M
$0.16
RFL Rafael Holdings, Inc.
VECTR System and other devices place the company under Medical Devices & Biometrics as a broader category.
$46.67M
$1.33
-1.48%
BDSX Biodesix, Inc.
Biodesix's Nodify and VeriStrat are blood-based diagnostic tests, i.e., liquid biopsy products.
$46.46M
$7.54
+18.85%
VNRX VolitionRx Limited
VolitionRx's Nu.Q platform enables liquid biopsy cancer diagnostics by detecting nucleosome/epigenetic biomarkers in blood.
$45.13M
$0.45
+3.49%
NOTV Inotiv, Inc.
Provides outsourced laboratory testing and advisory services in nonclinical toxicology and related analyses.
$42.60M
$1.15
-7.66%
ZJYL Jin Medical International Ltd.
The company designs, manufactures, and sells rehabilitation medical devices and biometrics-oriented equipment.
$42.56M
$0.24
-11.13%
CELU Celularity Inc.
The company uses placental-derived biomaterials and filings indicate medical device/biomaterial product development.
$41.19M
$1.69
-2.03%
ICCM IceCure Medical Ltd
IceCure manufactures liquid nitrogen-based cryoablation medical devices (ProSense/XSEN) used for tumor destruction, i.e., medical devices & biometrics.
$39.86M
$0.73
-0.19%
ELUT Elutia Inc.
Elutia's EluPro is a cardiology device used with cardiac implanted electronic devices (CIEDs), directly tying to Cardiology Devices.
$38.45M
$0.92
-1.51%
ECOR electroCore, Inc.
Directly markets and sells neuromodulation medical devices (gammaCore, Quell, Truvaga, Sparrow Ascent, TAC-STIM).
$37.70M
$4.91
-3.44%
YI 111, Inc.
Private label medical devices and biometrics offerings under the healthcare product lineup.
$37.46M
$4.39
+0.76%
RMTI Rockwell Medical, Inc.
Rockwell Medical's core offerings are dialysis-related consumables (acid and bicarbonate concentrates, single-use bicarbonate cartridge, and at-home packs) used with dialysis equipment.
$36.91M
$1.01
-6.02%
KTCC Key Tronic Corporation
Vietnam medical device manufacturing capability highlighted, aligning with Medical Devices & Biometrics.
$36.70M
$3.46
+2.67%
RDGL Vivos Inc.
The company designs, develops, and sells medical devices (RadioGel/IsoPet) used in oncology.
$36.05M
$0.08
NMTC NeuroOne Medical Technologies Corporation
Core product category: neuromodulation devices used to treat epilepsy and pain via brain stimulation and ablation.
$36.01M
$0.75
-2.19%
ZYXI Zynex, Inc.
Directly manufactures medical devices and biometrics used for patient monitoring and non-opioid pain management.
$35.08M
$1.17
+0.86%
MDCX Medicus Pharma Ltd. Common Stock
D-MNA is a medical device delivering therapy; fits Medical Devices & Biometrics.
$34.98M
$2.23
-4.70%
VRCA Verrica Pharmaceuticals Inc.
YCANTH's delivery includes a medical device component (drug-device combo applicator).
$32.93M
$3.45
-3.09%
LESL Leslie's, Inc.
AccuBlue water-testing systems and related diagnostic testing capabilities are direct testing instruments offered to customers.
$32.63M
$3.50
-0.43%
POCI Precision Optics Corporation, Inc.
The business includes design and manufacture of components/subassemblies for medical devices, i.e., Medical Device Components.
$32.12M
$4.08
-2.63%
PRPO Precipio, Inc.
Laboratory testing and advisory services as outsourced testing and regulatory support.
$30.35M
$20.90
+4.66%
MYO Myomo, Inc.
MyoPro is a prosthetic upper-limb device designed to replace or assist movement for partially paralyzed limbs, fitting Prosthetics & Implants.
$30.24M
$0.82
-5.84%
DRIO DarioHealth Corp.
Integrated Medical Devices & Biometrics (smart glucose meters and biofeedback sensors) are part of the offering.
$30.19M
$13.51
-1.67%
MODD Modular Medical, Inc.
MODD directly manufactures insulin pumps (MODD1 and Pivot), a core medical device product category categorized under Medical Devices & Biometrics.
$30.17M
$0.53
-4.33%
BDMD Baird Medical Investment Holdings Limited
BDMD is a medical device manufacturer focused on microwave ablation systems and related hardware, a core medical devices category.
$29.92M
$1.20
+0.84%
MLSS Milestone Scientific Inc.
Direct dental equipment manufacturing (DPS-based systems and related dental devices) as the dental segment is a core business.
$29.70M
$0.42
-0.86%
RBOT Vicarious Surgical Inc.
The company directly manufactures and sells surgical equipment in a robotic system for minimally invasive surgery.
$29.42M
$4.60
-7.26%
HBIO Harvard Bioscience, Inc.
HBIO generates recurring revenue from consumables used with its medical devices and bioproduction platforms (biochips, reagents, etc.).
$27.25M
$0.58
+1.05%
WETH Wetouch Technology Inc.
Medical applications revenue suggests involvement as a component provider in medical devices, i.e., Medical Device Components.
$26.97M
$2.17
BMGL Basel Medical Group Ltd Ordinary Shares
BMGL provides hospital-style healthcare services, including inpatient/outpatient care via clinics and integrated care delivery.
$26.76M
$1.50
-3.55%
RVP Retractable Technologies, Inc.
Core product category directly manufactured and sold: passive-safety syringes designed to prevent needlestick injuries.
$26.37M
$0.87
-1.38%
TLPH Talphera, Inc.
Ready-to-use syringe formats place Talphera in the medical devices/biometrics category related to injectable drug delivery.
$26.24M
$1.30
-7.45%
CLGN CollPlant Biotechnologies Ltd.
CollPlant's regenerative implants and dermal fillers are medical devices, aligning with Medical Devices & Biometrics.
$26.12M
$2.20
-3.51%
NSYS Nortech Systems Incorporated
Medical Device Components manufacturing and assembly for regulated markets.
$25.86M
N/A
NXL Nexalin Technology, Inc.
Core product is non-invasive neuromodulation devices for brain stimulation (Gen-2 SYNC, Gen-3 HALO).
$25.25M
$1.39
-5.44%
KPEA Kun Peng International Ltd.
The business includes health care equipment-based services and devices, aligning with medical devices & equipment.
$25.16M
$0.06
GTHP Guided Therapeutics, Inc.
LuViva is a point-of-care diagnostic device used for cervical cancer screening, which aligns with Diagnostic Equipment.
$21.68M
$0.27
CLSD Clearside Biomedical, Inc.
SCS Microinjector is a medical device used for ophthalmology applications (back-of-eye injections).
$21.19M
$4.01
-1.96%
ALLR Allarity Therapeutics, Inc.
Allarity provides laboratory services linked to its DRP companion diagnostics; falls under laboratory testing/advisory services.
$20.81M
$1.25
-9.78%
ACUT Accustem Sciences Inc.
Company plans to offer Laboratory Testing & Advisory Services leveraging existing lab infrastructure and additional sequencing/heritage panels.
$19.45M
$1.21
NRXS NeurAxis, Inc.
Core product line: Neuromodulation devices (IB-Stim PENFS).
$19.34M
$2.57
-4.10%
TOMZ TOMI Environmental Solutions, Inc.
Product category aligns with healthcare-themed medical devices and equipment, including disinfection hardware (SteraMist SIS/CES).
$18.29M
$0.91
-0.09%
PETV PetVivo Holdings, Inc.
PetVivo's Spryng is a veterinarian-administered medical device/biomaterial for osteoarthritis in dogs and horses.
$18.16M
$1.46
← Previous
1 ... 7 8 9 10 11 ... 12
Next →
Showing page 9 of 12 (1108 total stocks)

Loading company comparison...

Loading research report...

BDMD Baird Medical Investment Holdings Limited

Baird Medical Completes First Bone Tumor Ablation in Egypt, Expanding MWA Presence in MENA Region

Nov 03, 2025
MODD Modular Medical, Inc.

Modular Medical Validates Pivot Manufacturing Line Ahead of Q1 2026 Launch

Nov 03, 2025
NXL Nexalin Technology, Inc.

Nexalin Receives Israeli Ministry of Health Approval for Gen‑2 SYNC Neurostimulation Device

Oct 30, 2025
MODD Modular Medical, Inc.

Modular Medical Completes Stage 1 ISO 13485 Audit for CE Mark Certification of Pivot Insulin Delivery System

Oct 28, 2025
PETV PetVivo Holdings, Inc.

PetVivo Adds Josh Ruben, Managing Director of Life Sciences at Trinity Capital, to Board of Directors

Oct 28, 2025
BDMD Baird Medical Investment Holdings Limited

Baird Medical Announces First Successful Liver Tumor Ablation in Bangladesh

Oct 23, 2025
BDSX Biodesix, Inc.

Biodesix Expands Partnership with Bio‑Rad to Develop High‑Complexity Droplet Digital PCR Assays

Oct 22, 2025
NXL Nexalin Technology, Inc.

Nexalin Announces Three Peer‑Reviewed Studies Demonstrating Efficacy of Gen‑2 DIFS Technology in Alzheimer’s Patients

Oct 21, 2025
ZYXI Zynex, Inc.

Zynex Appoints Bret Wise as Board Member and Audit Committee Chair

Oct 15, 2025
ICCM IceCure Medical Ltd

IceCure's ProSense® Showcased at TME Fall Summit, Highlighting Cryoablation Advances Post-FDA Authorization

Oct 13, 2025
NXL Nexalin Technology, Inc.

Nexalin Technology Expands Scientific Advisory Board with Appointment of Dr. Robert Rothstein

Oct 13, 2025
VNRX VolitionRx Limited

VolitionRx Announces Proposed Public Offering of Common Stock and Warrants

Oct 10, 2025
ICCM IceCure Medical Ltd

IceCure Medical to Attend Maxim Growth Summit Following Landmark FDA Authorization

Oct 09, 2025
ICCM IceCure Medical Ltd

IceCure Medical's ProSense® Cryoablation Granted Landmark FDA Marketing Authorization for Low-Risk Breast Cancer in Women Aged 70+

Oct 03, 2025
ICCM IceCure Medical Ltd

IceCure's ProSense® Showcased at European Society of Breast Imaging Congress 2025, Highlighting De-Escalation of Care

Sep 30, 2025
ICCM IceCure Medical Ltd

IceCure's ProSense® Featured at CIRSE 2025 Annual Meeting with Positive Clinical Results from Independent Studies

Sep 22, 2025
ICCM IceCure Medical Ltd

IceCure Granted U.S. Patent Allowance for Next-Generation XSense™ Cryoprobes

Sep 18, 2025
ICCM IceCure Medical Ltd

IceCure Receives Israeli Regulatory Approval for Next-Generation XSense™ Cryoablation System

Sep 15, 2025
ICCM IceCure Medical Ltd

IceCure's ProSense® Cryoablation Achieves Highest Complete Ablation Rate in THERMAC Trial Publications

Sep 08, 2025
ICCM IceCure Medical Ltd

IceCure's ProSense® Significantly Reduces Abdominal Wall Endometriosis Pain in Independent Study

Sep 04, 2025
ICCM IceCure Medical Ltd

IceCure Reports H1 2025 Financial Results, Highlights Successful $10 Million Rights Offering

Aug 13, 2025
ICCM IceCure Medical Ltd

IceCure's $10 Million Rights Offering Closes Approximately Two Times Over-Subscribed

Jul 29, 2025
ICCM IceCure Medical Ltd

IceCure's ProSense® Showcases 99% Recurrence-Free Rate in Japanese Breast Cancer Study, Wins Award

Jul 25, 2025
ICCM IceCure Medical Ltd

IceCure Commences Rights Offering to Raise Up to $10 Million

Jul 10, 2025
ICCM IceCure Medical Ltd

IceCure Reports Preliminary Q2 2025 Financial Results with Revenue Impacted by Geopolitical Conflict

Jul 03, 2025
ICCM IceCure Medical Ltd

IceCure Announces Record Date for Rights Offering to Raise Up to $10 Million

Jun 25, 2025
ICCM IceCure Medical Ltd

IceCure Receives U.S. Patent Allowance for Novel Cryogen Flow Control to Optimize Patient Outcomes

Jun 09, 2025
ICCM IceCure Medical Ltd

IceCure Medical Reports Q1 2025 Financial Results, Secures Bridge Loan from Largest Shareholder

May 28, 2025
ICCM IceCure Medical Ltd

IceCure Reports High Interest from Breast Surgeons at ASBrS Annual Meeting Following Positive FDA Development

May 06, 2025
ICCM IceCure Medical Ltd

FDA Outlines Clear Path for IceCure's ProSense® Marketing Authorization in Early-Stage Breast Cancer for Women 70+

Apr 30, 2025
ICCM IceCure Medical Ltd

IceCure Exhibits ProSense® and Sponsors Sold-Out Breast Cryoablation Courses at SBI Symposium

Apr 28, 2025
BDMD Baird Medical Investment Holdings Limited

Baird Medical Advances Global Expansion with FDA CFG for Egypt and Multiple New Regulatory Applications

Apr 09, 2025
ICCM IceCure Medical Ltd

IceCure Medical Reports Full Year 2024 Financial Results, 42% North American Sales Growth

Mar 27, 2025
ICCM IceCure Medical Ltd

IceCure's ICESECRET Kidney Cancer Study Interim Results Presented at European Association of Urology Conference

Mar 24, 2025
ICCM IceCure Medical Ltd

FDA Marketing Authorization for IceCure's ProSense® Breast Cancer Indication Delayed Beyond Q1 2025

Mar 20, 2025
ICCM IceCure Medical Ltd

IceCure's ProSense® Featured in Six Studies at St. Gallen International Breast Cancer Conference

Mar 18, 2025
BDMD Baird Medical Investment Holdings Limited

Baird Medical's AI Tumor Ablation Surgical Robot Wins "Most Valuable Investment Award"

Mar 17, 2025
ICCM IceCure Medical Ltd

IceCure Receives China Patent Allowance for Novel Cryogenic Pump for Next-Generation Cryoablation Technology

Mar 17, 2025
BDMD Baird Medical Investment Holdings Limited

Baird Medical Secures Indonesian Regulatory Approval for Microwave Ablation Technology

Mar 10, 2025
ICCM IceCure Medical Ltd

Japanese Study Reports Higher Patient Satisfaction with IceCure's ProSense® Cryoablation for Breast Cancer

Mar 10, 2025
ICCM IceCure Medical Ltd

IceCure Submits Next-Generation XSense™ Cryoablation System for Regulatory Approval in Israel

Feb 24, 2025
ICCM IceCure Medical Ltd

IceCure's ProSense®-Featured THERMAC Trial Wins 'Highest Scoring Abstract' at SIO Annual Meeting

Feb 04, 2025
ICCM IceCure Medical Ltd

IceCure Files for Regulatory Approval of ProSense® Cryoablation System in China

Jan 27, 2025
BDMD Baird Medical Investment Holdings Limited

Baird Medical Expands U.S. Presence with San Francisco Entry and Hundreds of Patient Treatments

Jan 22, 2025
BDMD Baird Medical Investment Holdings Limited

Dr. Emad Kandil Reaches 100 Microwave Ablation Cases in Thyroid Care

Jan 21, 2025
ICCM IceCure Medical Ltd

IceCure Medical CEO Highlights 42% North American Sales Growth in 2024, Positive Clinical Data, and IP Expansion

Jan 13, 2025
ICCM IceCure Medical Ltd

IceCure Medical Regains Full Nasdaq Compliance with Minimum Bid Price Rule

Jan 06, 2025
ICCM IceCure Medical Ltd

European Patent Office Issues Intention to Grant Notice for IceCure's Next-Generation Cryoablation Technology

Jan 03, 2025
BDMD Baird Medical Investment Holdings Limited

Baird Medical Convenes 2024 Annual Review and Charts 2025 Strategic Vision

Dec 10, 2024
ICCM IceCure Medical Ltd

IceCure's ICESECRET Kidney Cancer Study Interim Results Show 88.7% Recurrence-Free Rate

Dec 05, 2024

The most compelling investment themes are the ones nobody is talking about yet.

Every Monday, get three under-the-radar themes with catalysts, data, and stocks poised to benefit.

Sign up now to receive them!

Also explore our analysis on 5,000+ stocks